Chinese Drugmaker Innogen Soars in Hong Kong Debut

Published 2 months ago • Aug 15, 2025 at 3:16 AM • Positive

Auto

Related Stocks

Guangzhou Innogen Pharmaceutical Group, a Chinese biotech firm looking to tap the vast domestic market for obesity drugs, surged as much as 296% in its trading debut in Hong Kong. Its founder, chairman and CEO Qinghua Wang speaks exclusively on "Bloomberg: The China Show."

View comments

More News

Dimensional Fund Advisors Ltd. : Form 8.3 - TT ELECTRONICS PLC - Ordinary Shares

13 minutes ago Positive

Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares

14 minutes ago Positive

Multi-Tenant Data Centers Business Analysis Report 2025: Market to Reach $91 Billion by 2030, Driven by Growing Demand for Scalable IT Infrastructure and Rise in 5G Deployments

16 minutes ago Positive

Dimensional Fund Advisors Ltd. : Form 8.3 - DOWLAIS GROUP PLC - Ordinary Shares